Discover
EBS
Emergent BioSolutions Inc.
7.06
400 x 6.98
400 x 6.99
bid
ask
+
0.25
3.67%
400 @ 07:15 PM
7.01 -0.05 (0.71%)
| Ytd | -42.88% | |
| 1y | -29.68% |
6.61
day range
7.06
4.45
52 week range
13.90
| Open | 6.73 | Prev Close | 6.81 | Low | 6.61 | High | 7.06 | Mkt Cap | 361.99M |
| Vol | 850.97K | Avg Vol | 1.17M | EPS | -3.40 | P/E | N/A | Forward P/E | 2.73 |
| Beta | 1.57 | Short Ratio | 4.54 | Inst. Own | 60.02% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 10-28 | 50-d Avg | 6.11 | 200-d Avg | 8.49 | 1yr Est | 12.00 |
EBS News
zacks.com
Emergent Biosolutions (EBS) Soars 14.4%: Is Further Upside Left in the Stock?
Emergent Biosolutions (EBS) was a big mover last session on higher-than-average trading volume. The
benzinga.com
Novavax Shorts on Edge as Russia Plague Fears Spread
Unconfirmed plague fears sent Novavax up 24% in a potential short squeeze, lifting vaccine stocks de
invezz.com
Russian plague outbreak could boost these under-the-radar pharma stocks
Global biosecurity alarms are flashing after an incident at an anti-plague research facility in Sibe
defenseworld.net
Emergent Biosolutions (NYSE:EBS) Stock: Insider Paul Anthony Williams Sells 3,000 Shares
Emergent Biosolutions Inc. (NYSE: EBS - Get Free Report) SVP Paul Williams sold 3,000 shares of the
defenseworld.net
Emergent Biosolutions Inc. (NYSE:EBS) Stock Has Consensus Price Target of $10.00
Emergent Biosolutions Inc. (NYSE: EBS - Get Free Report) has received an average recommendation of "